# VYRIAD, INC.: Off-the-shelf in vivo CAR-T therapy for multiple myeloma

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | VYRIAD, INC. |
| Location | ROCHESTER, MN |
| Project | Off-the-shelf in vivo CAR-T therapy for multiple myeloma |
| Project number | 1R44CA314911-01 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $1,044,729 |
| Awarded | 2026-09-07 |
| Project period | 2026-09-07 to 2028-08-31 |
| UEI | P4J2W42KVHQ7 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11410209). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.